Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Collaboration between industry and HCPs drives medical innovation and leads to better patient care. Some of the ways Medtronic collaborates with HCPs include:
Other HCPs to use or implement our medical devices and therapies.
The CoreValve System is a new way to treat severe aortic stenosis for patients for whom surgery is not recommended. Medtronic’s education and training programs help HCPs to safely adopt this therapy. Part of the program involves training by HCP proctors who have direct patient access and are highly trained and experienced in the new therapy. The HCP proctors visit sites where other heart HCPs are getting started with the therapy, and to help ensure that procedural best practices for the CoreValve System are being followed.
We are proud of our work with HCPs and have policies to ensure our interactions with HCPs are principled and appropriate.
We understand the importance of public trust in collaboration and are committed to transparency in an effort to increase patient confidence and project our ability to work with HCPs.
We are hopeful that the CMS Open Payments Database will be a move to consistent reporting of HCP collaboration across our industry, protecting our ability to continue to pursue this important interaction for the benefit of patients.
Years before the Open Payments Database was mandated as part of the 2010 Affordable Care Act, Medtronic was taking steps to eliminate conflicts of interest and ensure that treatment decisions are driven by patient needs and HCP expertise.
Medtronic's first revolutionary product, a wearable pacemaker, was developed through a close collaboration between our founder Earl Bakken and a University of Minnesota Medical School heart surgeon.
Deep brain stimulation to treat Parkinson's disease and insulin pump therapy are other Medtronic innovations born by collaboration.
HCPs collaborating with industry has led to the development of penicillin, cortisone, CAT scans, laser eye surgery, oral contraceptives, vaccines for chickenpox and hepatitis B, and total knee replacement.
Medtronic believes transparency is necessary to maintain public trust in our collaboration. Medtronic invested millions of dollars to develop sound, accurate reporting systems and processes to ensure that we could report data in compliance with CMS regulations.
With more than four years of experience reporting HCP payments, Medtronic will continue to provide feedback to CMS in support of the continued evolution of the CMS Open Payments Database.
The ability to collaborate with HCPs is an important issue for the medical device and pharmaceutical industries. Learn about what other organisations are doing: